Correlation Between BB Biotech and SPDR Dow
Can any of the company-specific risk be diversified away by investing in both BB Biotech and SPDR Dow at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BB Biotech and SPDR Dow into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BB Biotech AG and SPDR Dow Jones, you can compare the effects of market volatilities on BB Biotech and SPDR Dow and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BB Biotech with a short position of SPDR Dow. Check out your portfolio center. Please also check ongoing floating volatility patterns of BB Biotech and SPDR Dow.
Diversification Opportunities for BB Biotech and SPDR Dow
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between BION and SPDR is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding BB Biotech AG and SPDR Dow Jones in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SPDR Dow Jones and BB Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BB Biotech AG are associated (or correlated) with SPDR Dow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SPDR Dow Jones has no effect on the direction of BB Biotech i.e., BB Biotech and SPDR Dow go up and down completely randomly.
Pair Corralation between BB Biotech and SPDR Dow
Assuming the 90 days trading horizon BB Biotech AG is expected to under-perform the SPDR Dow. In addition to that, BB Biotech is 1.31 times more volatile than SPDR Dow Jones. It trades about -0.04 of its total potential returns per unit of risk. SPDR Dow Jones is currently generating about -0.02 per unit of volatility. If you would invest 1,800 in SPDR Dow Jones on September 16, 2024 and sell it today you would lose (31.00) from holding SPDR Dow Jones or give up 1.72% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
BB Biotech AG vs. SPDR Dow Jones
Performance |
Timeline |
BB Biotech AG |
SPDR Dow Jones |
BB Biotech and SPDR Dow Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with BB Biotech and SPDR Dow
The main advantage of trading using opposite BB Biotech and SPDR Dow positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BB Biotech position performs unexpectedly, SPDR Dow can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SPDR Dow will offset losses from the drop in SPDR Dow's long position.BB Biotech vs. Swiss Life Holding | BB Biotech vs. Swiss Re AG | BB Biotech vs. Helvetia Holding AG | BB Biotech vs. Partners Group Holding |
SPDR Dow vs. Baloise Holding AG | SPDR Dow vs. 21Shares Polkadot ETP | SPDR Dow vs. UBS ETF MSCI | SPDR Dow vs. BB Biotech AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |